- Report
- February 2026
- 168 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- January 2026
- 187 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- February 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- July 2024
- 120 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- April 2023
- 119 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- November 2025
- 132 Pages
Global
From €832EUR$950USD£722GBP
- Report
- November 2021
- 270 Pages
Global
From €2190EUR$2,500USD£1,900GBP
The Peptide Microarray market is a subset of the biotechnology industry that focuses on the development and production of peptide microarrays. These microarrays are used to detect and measure the presence of peptides in a sample, and are used in a variety of research and clinical applications. Peptide microarrays are used to identify biomarkers, measure drug efficacy, and study protein-protein interactions. They are also used to study the effects of post-translational modifications on protein function.
The Peptide Microarray market is highly competitive, with a number of companies offering products and services. Companies in the market include Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more